![](https://guardian.ng/wp-content/uploads/2024/06/HIV-DRUG-1024x576.jpg)
Rising out-of-pocket costs for PrEP threaten key strategy in ending HIV epidemic
Increasing patients’ out of pocket costs for HIV pre-exposure prophylaxis (PrEP), medications, which have been shown to dramatically reduce the risk of HIV infection, could lead to a significant reduction in PrEP